Biochemical Characterization of Human Salivary Extracellular Vesicles as a Valuable Source of Biomarkers.
Valentina Mangolini, Alice Gualerzi, Silvia Picciolini...
https://pubmed.ncbi.nlm.nih.gov/36829504/Actively Recruiting
Led by Fondazione Don Carlo Gnocchi Onlus · Updated on 2025-08-07
242
Participants Needed
5
Research Sites
41 weeks
Total Duration
Researchers are studying neurodegenerative diseases NDDs such as Parkinsons disease, atypical parkinsonisms, Alzheimers disease, prodromal Parkinsons disease, and mild cognitive impairment. The study focuses on early diagnosis and patient profiling using a novel, cost-effective biophotonic method involving Raman spectroscopy to analyze saliva and saliva-derived extracellular vesicles sEVs. This research aims to identify specific biochemical markers that can help in early detection, disease differentiation, and monitoring progression to improve personalized treatment strategies. Participants will provide saliva samples at enrollment and after 12 months to analyze biochemical changes using Raman spectroscopy. The study involves examining saliva and sEVs with advanced techniques to isolate and characterize extracellular vesicles. Data analysis will include molecular profiling and longitudinal evaluation to correlate biochemical fingerprints with disease stages and clinical assessments. The study includes groups representing different neurodegenerative conditions with a total minimum of 242 subjects. During the study, participants will undergo saliva collection using specialized swabs and provide demographic and clinical data, which will be pseudonymized and securely stored. Researchers will measure biochemical markers related to neurodegeneration and use Raman spectroscopy to create diagnostic profiles. Follow-up saliva samples and clinical evaluations after one year will help monitor disease progression. The primary outcome is the salivary Raman fingerprint distinguishing disease groups, with secondary outcomes including biomolecular evaluations and correlation with clinical data over 12 months.
CONDITIONS
Saliva and Extracellular Vesicles for Neurodegenerative Diseases
P
Pietro Arcuri, MD
A
Alice Gualerzi, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fondazione Don Carlo Gnocchi Onlus
Lead Sponsor
Fondazione Regionale per la Ricerca Biomedica
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants provide saliva samples and undergo clinical assessments at enrollment to identify neurodegenerative disease biomarkers.
1 baseline visit (in-person)
Duration - 12 months
Participants provide a second saliva sample and undergo follow-up assessments approximately 12 months after enrollment to monitor disease progression.
1 follow-up visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Valentina Mangolini, Alice Gualerzi, Silvia Picciolini...
https://pubmed.ncbi.nlm.nih.gov/36829504/Cristiano Carlomagno, Dario Bertazioli, Alice Gualerzi...
https://pubmed.ncbi.nlm.nih.gov/34764849/Fondazione Don Carlo Gnocchi Onlus
Lead Sponsor
Fondazione Regionale per la Ricerca Biomedica
Collaborating Sponsor